The campaign is launching alongside positive news for the company’s Phase 3 trials for a GBS treatment. Annexon Biosciences launched a new campaign to raise awareness with HCPs about the risk of ...
BRISBANE, Calif., April 08, 2025 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results